Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 3 SUPPL., 2012, Pages

  Orange, Jordan S ^a   Ballow, Mark ^b   Stiehm, E Richard ^c   Ballas, Zuhair K ^d   Chinen, Javier ^a   De La Morena, Maite ^e   Kumararatne, Dinakantha ^f   Harville, Terry O ^g   Hesterberg, Paul ^h   Koleilat, Majed ⁱ   McGhee, Sean ^c   Perez, Elena E ^j   Raasch, Jason ^k   Scherzer, Rebecca ^l   Schroeder, Harry ^m   Seroogy, Christine ⁿ   Huissoon, Aarnoud ^o   Sorensen, Ricardo U ^p   Katial, Rohit ^q  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

^c MATTEL CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Deaconess Clinic   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k Midwest Immunology Clinic   (United States)

^l OHIO STATE UNIVERSITY   (United States)

^m UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF WISCONSIN MADISON   (United States)

^o BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^p LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^q UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

antibody deficiency; antigen challenge; common variable immunodeficiency; diagnosis; guideline; neoantigen; primary immunodeficiency; specific antibody deficiency; Vaccines

Indexed keywords

ADENOVIRUS 4 VACCINE; ADENOVIRUS 7 VACCINE; ANTHRAX VACCINE; BCG VACCINE; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DECAVAC; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; DIPLOID CELL VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TENIVAC; TYPHOID VACCINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; VIRUS VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ANTIBODY RESPONSE; ARTICLE; DIAGNOSTIC VALUE; HUMAN; IMMUNE DEFICIENCY; MEDICAL EXPERT; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; VACCINATION;

BACTERIAL CAPSULES; BACTERIOPHAGE PHI X 174; HAEMOPHILUS VACCINES; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC DEFICIENCY SYNDROMES; PNEUMOCOCCAL VACCINES; RABIES VACCINES; SALMONELLA VACCINES; VACCINATION;

EID: 84862865305     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.07.002     Document Type: Article

References (167)

1. M. Morra, U. Geigenmuller, J. Curran, I.R. Rainville, T. Brennan, and J. Curtis Genetic diagnosis of primary immune deficiencies Immunol Allergy Clin North Am 28 2008 387 412
2. L.D. Notarangelo, A. Fischer, R.S. Geha, J.L. Casanova, H. Chapel, and M.E. Conley Primary immunodeficiencies: 2009 update J Allergy Clin Immunol 124 2009 1161 1178
3. C. Wehr, T. Kivioja, C. Schmitt, B. Ferry, T. Witte, and E. Eren The EUROclass trial: defining subgroups in common variable immunodeficiency Blood 111 2008 77 85
4. F. Bonilla, I. Bernstein, D. Khan, J. Chinen, M. Frank, and L. Kobrynski Practice parameter for the diagnosis and management of primary immunodeficiency Ann Allergy Asthma Immunol 94 suppl 2005 S1-63
5. K. Zangwill, R. Stout, and G. Carlone Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel J Infect Dis 169 1994 847 852
6. D.F. Kelly, E.R. Moxon, and A.J. Pollard Haemophilus influenzae type b conjugate vaccines Immunology 113 2004 163 174
7. D.M. Granoff, E.L. Anderson, M.T. Osterholm, S.J. Holmes, J.E. McHugh, and R.B. Belshe Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants J Pediatr 121 1992 187 194
8. P. Anderson The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b J Infect Dis 149 1984 1034 1035
9. P.C. Fusco, M.S. Blake, and F. Michon Meningococcal vaccine development: a novel approach Expert Opin Investig Drugs 7 1998 245 252
10. S. Choo, J. Zuckerman, C. Goilav, E. Hatzmann, J. Everard, and A. Finn Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial Vaccine 18 2000 2686 2692
11. H. Peltola, H. Makela, H. Kayhty, H. Jousimies, E. Herva, and K. Hallstrom Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age N Engl J Med 297 1977 686 691
12. T.L. McCool, C.V. Harding, N.S. Greenspan, and J.R. Schreiber B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity Infect Immun 67 1999 4862 4869
13. R.L. Jones, J.E. Froeschle, R.L. Atmar, J.S. Matthews, R. Sanders, and J. Pardalos Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine Vaccine 19 2001 4635 4643
14. J. Morris, N.S. Crowcroft, A.R. Fooks, S.M. Brookes, and N. Andrews Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination Human vaccines 3 2007 165 170
15. D. Evans Persistence of antitoxin in man following active immunisation Lancet 242 1943 316 317
16. P.J. Gergen, G.M. McQuillan, M. Kiely, T.M. Ezzati-Rice, R.W. Sutter, and G. Virella A population-based serologic survey of immunity to tetanus in the United States N Engl J Med 332 1995 761 766
17. S. Goldacker, R. Draeger, K. Warnatz, D. Huzly, U. Salzer, and J. Thiel Active vaccination in patients with common variable immunodeficiency (CVID) Clinical Immunol 124 2007 294 303
18. N. Rezaei, A. Aghamohammadi, S. Siadat, M. Nejati, H. Ahmadi, and M. Moin Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies Vaccine 25 2007 5308 5314
19. M.J. Rodrigo, M. Miravitlles, M.J. Cruz, J. de Gracia, M. Vendrell, and C. Pascual Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria Clin Diagn Lab Immunol 4 1997 168 172
20. S. Sanchez-Ramon, L. Radigan, J. Yu, S. Bard, and C. Cunningham-Rundles Memory B cells in common variable immunodeficiency: clinical associations and sex differences Clin Immunol 128 2008 314 321
21. E.R. Stiehm The four most common pediatric immunodeficiencies J Immunotoxicol 5 2008 227 234
22. J.M. Boyle, and R.H. Buckley Population prevalence of diagnosed primary immunodeficiency diseases in the United States J Clin Immunol 27 2007 497 502
23. S. Agarwal, and C. Cunningham-Rundles Assessment and clinical interpretation of reduced IgG values Ann Allergy Asthma Immunol 99 2007 281 283
24. J.S. Orange, E.M. Hossny, C.R. Weiler, M. Ballow, M. Berger, and F.A. Bonilla Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology J Allergy Clin Immunol 117 suppl 2006 S525 S553
25. I.B. Barlan, R.S. Geha, and L.C. Schneider Therapy for patients with recurrent infections and low serum IgG3 levels J Allergy Clin Immunol 92 1993 353 355
26. D.T. Umetsu, D.M. Ambrosino, I. Quinti, G.R. Siber, and R.S. Geha Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency N Engl J Med 313 1985 1247 1251
27. C. Lacombe, P. Aucouturier, and J.L. Preud'homme Selective IgG1 deficiency Clin Immunol Immunopathol 84 1997 194 201
28. M. Armenaka, J. Grizzanti, and D.L. Rosenstreich Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels Ann Allergy 72 1994 507 514
29. J.P. Shield, S. Strobel, R.J. Levinsky, and G. Morgan Immunodeficiency presenting as hypergammaglobulinaemia with IgG2 subclass deficiency Lancet 340 1992 448 450
30. I. Dalal, B. Reid, E. Nisbet-Brown, and C. Roifman The outcome of patients with hypogammaglobulinemia in infancy and early childhood J Pediatr 133 1998 144 146
31. M.J. Dorsey, and J.S. Orange Impaired specific antibody response and increased B-cell population in transient hypogammaglobulinemia of infancy Ann Allergy Asthma Immunol 97 2006 590 595
32. V. Moschese, S. Graziani, M. Avanzini, R. Carsetti, M. Marconi, and M. La Rocca A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network Int J Immunopathol Pharmacol 21 2008 343 352
33. H. Ochs, S. Slichter, L. Harker, W. Von Behrens, R. Clark, and R. Wedgwood The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets Blood 55 1980 243 252
34. K. Sullivan, C. Mullen, R. Blaese, and J. Winkelstein A multiinstitutional survey of the Wiskott-Aldrich syndrome J Pediatr 125 1994 876 885
35. M. Guerra-Maranhao, B. Costa-Carvalho, V. Nudelman, P. Barros-Nunes, M. Carneiro-Sampaio, and C. Arslanian Response to polysaccharide antigens in patients with ataxia-telangiectasia J Pediatr (Rio J) 82 2006 132 136
36. O. Sanal, F. Ozbas-Gerceker, L. Yel, F. Ersoy, I. Tezcan, and A. Berkel Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia Turk J Pediatr 46 2004 208 213
37. A. Stray-Pedersen, I. Aaberge, A. Fruh, and T. Abrahamsen Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia Clin Exp Immunol 140 2005 507 516
38. A. Finocchi, S. Di Cesare, M. Romiti, C. Capponi, P. Rossi, and R. Carsetti Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome) Pediatr Allergy Immunol 17 2006 382 388
39. A. Gennery, D. Barge, J. O'Sullivan, T. Flood, M. Abinun, and A. Cant Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome Arch Dis Child 86 2002 422 425
40. L. Botto, K. May, P. Fernhoff, A. Correa, K. Coleman, and S. Rasmussen A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population Pediatrics 112 2003 101 107
41. M. Leinonen, A. Sakkinen, R. Kalliokoski, J. Luotonen, M. Timonen, and P.H. Makela Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children Pediatr Infect Dis 5 1986 39 44
42. T.L. Tiller Jr., and R.H. Buckley Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up J Pediatr 92 1978 347 353
43. M.A. Avanzini, A.M. Carra, R. Maccario, M. Zecca, P. Pignatti, and M. Marconi Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation J Clin Immunol 15 1995 137 144
44. A. Balloch, P.V. Licciardi, F.M. Russell, E.K. Mulholland, and M.L. Tang Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine J Allergy Clin Immunol 126 2011 395 397
45. X. Bossuyt, H. Borgers, L. Moens, B. Verbinnen, and I. Meyts Age- and serotype-dependent antibody response to pneumococcal polysaccharides J Allergy Clin Immunol 127 2011 1079 1080 author reply 80-1
46. I.D. Riley, D. Lehmann, M.P. Alpers, T.F. Marshall, H. Gratten, and D. Smith Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children Lancet 2 1986 877 881
47. F. Arredondo-Vega, I. Santisteban, S. Daniels, S. Toutain, and M. Hershfield Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles Am J Hum Genet 63 1998 1043 1059
48. H. Ozsahin, F.X. Arredondo-Vega, I. Santisteban, H. Fuhrer, P. Tuchschmid, and W. Jochum Adenosine deaminase deficiency in adults Blood 89 1997 2849 2855
49. P.M. Wood, A. Mayne, H. Joyce, C.I. Smith, D.M. Granoff, and D.S. Kumararatne A mutation in Bruton's tyrosine kinase as a cause of selective anti-polysaccharide antibody deficiency J Pediatr 139 2001 148 151
50. D.H. Smith, G. Peter, D.L. Ingram, A.L. Harding, and P. Anderson Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b Pediatrics 52 1973 637 644
51. E.S. Go, and Z.K. Ballas Anti-pneumococcal antibody response in normal subjects: a meta-analysis J Allergy Clin Immunol 98 1996 205 215
52. N.D. Hare, B.J. Smith, and Z.K. Ballas Antibody response to pneumococcal vaccination as a function of preimmunization titer J Allergy Clin Immunol 123 2009 195 200
53. N. Bakare, D. Menschik, R. Tiernan, W. Hua, and D. Martin Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS) Vaccine 28 2010 6609 6612
54. M. Sadeghi-Shabestari, and N. Rezaei Disseminated Bacille Calmette-Guerin in Iranian children with severe combined immunodeficiency Int J Infect Dis 13 2009 e420 e423
55. F. Ghaffar, K. Carrick, B.B. Rogers, L.R. Margraf, K. Krisher, and O. Ramilo Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency Pediatr Infect Dis J 19 2000 764 766
56. H. Inaba, H. Hori, M. Ito, M. Kuze, H. Ishiko, and B.I. Asmar Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia Scand J Infect Dis 33 2001 630 631
57. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence MMWR Recomm Rep 42 1993 1 18
58. AAP Pneumococcal infections L. Pickering, C. Baker, S. Long, D. Kimberlin, S. Long, Red Book: 2009 report of the Committee on Infectious Diseases 28th ed. 2009 American Academy of Pediatrics Elk Grove Village (IL) 524 535
59. K. Paris, and R. Sorensen Assessment and clinical interpretation of polysaccharide antibody responses Ann Allergy Asthma Immunol 99 2007 462 464
60. J.C. Butler Epidemiology of pneumococcal serotypes and conjugate vaccine formulations Microb Drug Resist 3 1997 125 129
61. S. Black, J. Eskola, C. Whitney, and H. Shinefield Pneumococcal conjugate vaccine and pneumococcal common protein vaccines S. Plotkin, W. Orenstein, P. Offit, Vaccines 5th ed. 2006 Elsevier Philadelphia 521 567
62. CDCP Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 46 1997 1 24
63. L. Jackson, and K. Neuzil Pneumococcal vaccines S. Plotkin, W. Orenstein, P. Offit, Vaccines 5th ed. 2006 Elsevier St Louis 569 604
64. B. Simell, T. Kilpi, and H. Kayhry Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children J Infect Dis 186 2002 1106 1114
65. Q. Zhang, and A. Finn Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria J Clin Pathol 57 2004 1015 1021
66. J. Eskola Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media Vaccine 19 suppl 2001 S78 S82
67. P. Makela, E. Herva, and M. Sibakov Pneumococcal vaccine and otitis media Lancet 2 1980 547 551
68. M. Straetemans, E. Sanders, and R. Veenhoven Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media Pediatr Infect Dis J 22 2003 515 524
69. D.M. Musher, S.B. Manof, C. Liss, R.D. McFetridge, R.D. Marchese, and B. Bushnell Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults J Infect Dis 201 2010 516 524
70. N. Concepcion, and C. Frasch Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay Clin Diagn Lab Immunol 8 2001 266 272
71. R. Boyle, C. Le, and A. Balloch The clinical syndrome of specific antibody deficiency in children Clin Exp Immunol 146 2006 486 492
72. W. Kamchaisatian, W. Wanwatsuntikul, J.W. Sleasman, and N. Tangsinmankong Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children J Allergy Clin Immunol 118 2006 1336 1341
73. M. Rose, R. Schubert, and N. Strand Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine Clin Diagn Lab Immunol 12 2005 1216 1222
74. R. Sorensen, L. Leiva, and P. Giansgrosso Response to a heptavalent conjugate of Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine Pediatr Infect Dis J 17 1998 685 691
75. R. Sorensen, L. Leiva, and F. Javier III Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations J Allergy Clin Immunol 102 1998 215 221
76. R. Burton, and M. Nahm Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies Clin Vaccine Immunol 13 2006 1004 1009
77. S. Romero-Steiner, C. Frasch, G. Carlone, R. Fleck, D. Goldblatt, and M. Nahm Use of opsonophagocytosis for the serologic evaluation of pneumococcal vaccines Clin Vaccine Immunol 13 2006 165 169
78. S. Landesman, and G. Schiffman Assessment of the antibody response to pneumococcal vaccine in high-risk populations Rev Infect Dis 3 suppl 1981 S184 S196
79. H. Hidalgo, C. Moore, and L. Leiva Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections Ann Allergy Asthma Immunol 76 1996 341 346
80. S. Uddin, R. Borrow, and M. Haeneuy Total and serotype specific pneumococcal antibody titres in children with normal and abnormal humoral immunity Vaccine 24 2006 5637 5644
81. N. French, S.B. Gordon, T. Mwalukomo, S.A. White, G. Mwafulirwa, and H. Longwe A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults N Engl J Med 362 2010 812 822
82. E.A. Clutterbuck, P. Salt, S. Oh, A. Marchant, P. Beverley, and A.J. Pollard The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine Immunology 119 2006 328 337
83. L. Jodar, J. Butler, G. Carlone, R. Dagan, D. Goldblatt, and H. Kayhty Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants Vaccine 21 2003 3265 3272
84. L.H. Lee, C.E. Frasch, L.A. Falk, D.L. Klein, and C.D. Deal Correlates of immunity for pneumococcal conjugate vaccines Vaccine 21 2003 2190 2196
85. H.B. Konradsen Humoral immune response to pneumococcal vaccination. Prevention of infections with Streptococcus pneumoniae by immunization APMIS Suppl 60 1996 1 28
86. D.M. Granoff, R.K. Gupta, R.B. Belshe, and E.L. Anderson Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination J Infect Dis 178 1998 870 874
87. A. de Roux, B. Schmole-Thoma, G. Siber, J. Hackell, A. Kuhnke, and N. Ahlers Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory Clin Infect Dis 46 2008 1015 1023
88. K.L. O'Brien, M. Hochman, and D. Goldblatt Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 7 2007 597 606
89. M.D. Blum, R. Dagan, P.M. Mendelman, V. Pinsk, M. Giordani, and S. Li A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers Vaccine 18 2000 2359 2367
90. J. Southern, S. Deane, L. Ashton, R. Borrow, D. Goldblatt, and N. Andrews Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults Clin Diagn Lab Immunol 11 2004 1100 1104
91. D. Ambrosino, G. Siber, and B. Chilmonczyk An immunodeficiency characterized by impaired antibody responses to polysaccharides N Engl J Med 316 1987 790 793
92. L. Sanders, G. Rijkers, and W. Kuis Defective anti-pneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections J Allergy Clin Immunol 91 1993 110 119
93. J. Mond, and J. Kokai-Kun The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens Curr Top Microbiol Immunol 319 2008 17 40
94. A. Abbas, A. Lichtman, and S. Pillai B Cell Activation and Antibody Production A. Abbas, A. Lichtman, S. Pillai, Cellular and molecular immunology 6th ed. 2007 Saunders Philadelphia 215 241
95. J. Lieberman, S. Chiu, V. Wong, and S. Partridge Safety and immunogenicity of serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children JAMA 275 1996 1499 1503
96. R. Borrow, J. Southern, and N. Andrews Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naive controls Vaccine 19 2001 3043 3050
97. D. Vu, A. De Boer, and L. Danzig Priming for immunologic memory in adults by meningococcal group C conjugate vaccination Clin Vaccine Immunol 13 2006 605 610
98. D. Granoff, I. Feaverts, and R. Borrow Menningococcal vaccines S. Plotkin, W. Orenstein, Vaccines 4th ed. 2004 WB Saunders Co Philadelphia 954 987
99. P. Richmond, E. Kaczmarski, and R. Borrow Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine J Infect Dis 181 2000 761 764
100. A. Leach, P. Twumasi, and S. Kumah Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine J Infect Dis 175 1997 200 204
101. N. Macdonald, S. Halperin, and B. Law Induction of immunologic memory by conjugated vs. plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial JAMA 280 1998 1685 1689
102. A.S. Anderson, K.U. Jansen, and J. Elden New frontiers in meningococcal vaccines Expert Rev Vaccines 10 2011 617 634
103. J. MacLennan, S. Obaro, and J. Deeks Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood Vaccine 17 1999 3086 3093
104. M. Pichichero Meningococcal conjugate Vaccines Expert Opin Biol 5 2005 1475 1489
105. M. Burrage, A. Robinson, and R. Borrow Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection Infect Immun 70 2002 4946 4954
106. S. Maslanka, L. Gheesling, and D. Libutti Standardization and a multi-laboratory comparison of Neisseria meningitides serogroup A and C bactericidal assays Clin Diagn Lab Immunol 4 1997 156 157
107. D. Sikkema, and K. Friedman Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitides serogroup C vaccines Clin Diagn Lab Immunol 7 2000 764 768
108. E. Anderson, T. Bowers, and C. Mink Safety and immunogenicity of Meningococcal A and C polysaccharide conjugate vaccine in adults Infect Immun 62 2004 3391 3395
109. M. Rennels, K. Edwards, and H. Keyserling Safety and immunogenicity in four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants Pediatr Infect Dis J 20 2001 153 159
110. CDCP Prevention and control of meningococcal disease; recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 54 2005 1 21
111. CDCP Report from the Advisory Committee on Immunizations practices (ACIP): decision not to recommend routine vaccination of all children aged 2 - 10 years with quadrivalent meningococcal conjugate vaccine (MCV4) MMWR Morb Mortal Wkly Rep 57 2008 462 465
112. J. MacLennan, F. Shackley, and P. Heath Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial JAMA 283 2000 2795 2801
113. M. Pichichero Meningococcal conjugate vaccine in adolescents and children Clin Pediatr 44 2005 479 489
114. M. Pichichero, J. Cassey, and M. Blatter Comparative trial of the safety and immunogenicity of quadravalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine in two- to ten-year-old children Pediatr Infect Dis J 24 2005 57 62
115. S. Harris, A. Finn, and D. Granoff Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine. D Infect Immun 71 2003 3402 3408
116. O. Bilukha, and N. Messonnier Use of Meningococcal vaccines in the United States Pediatr Infect Dis J 26 2007 371 376
117. American Academy of Pediatrics Committee on Infectious Diseases Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients Pediatrics 116 2005 496 505
118. FDA Product approval information-licensing action, package insert: meningococcal (groups A, C, Y, W-135) polysaccharide vaccine Menomune 2005 US Department of Health and Human Services, Food and Drug Administration Rockville (MD)
119. N. Rosenstein, B. Perkins, and D. Stephens Meningococcal disease N Engl J Med 344 2001 1378 1388
120. M. Lepow, J. Beeler, and M. Randolph Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children J Infect Dis 154 1986 1033 1036
121. H. Keyserling, T. Papa, K. Koranyi, R. Ryall, E. Bassily, and M. Bybel Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents Arch Pediatr Adolesc Med 159 2005 907 913
122. J. MacLennan, and S. Obaro Immunologic memory 5 years after meningococcal IA/C conjugate vaccination in infancy J Infect Dis 183 2001 97 104
123. F. Mawas, R. Dickinson, and A. Douglas-Bardsley Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenza b (Hib) conjugate vaccine in a rat model Vaccine 24 2006 3505 3512
124. I. Goldschneider, E. Gotschlich, and M.S. Artenstein Human immunity to the meningococcus. II. Development of natural immunity J Exp Med 129 1969 1327 1348
125. A. Jäkel, J. Plested, J. Hoe, and K. Makepeace Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures Vaccine 26 2008 6655 6663
126. R.K. Katial, B.L. Brandt, E.E. Moran, S. Marks, V. Agnello, and W.D. Zollinger Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine Infect Immun 70 2002 702 707
127. M. Mikolajczyk, N. Concepcion, T. Wang, D. Frazier, B. Golding, and C. Frasch Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations Clin Diagn Lab Immunol 11 2004 1158 1164
128. H. Ochs, R. Buckley, R. Kobayashi, A. Kobayashi, R. Sorensen, and S. Douglas Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency Blood 80 1992 1163 1171
129. H. Ochs, D. Starkey, and R. Wedgwood Immunologic responses to bacteriophage φX174 in immunodeficiency diseases J Clin Invest 50 1971 2559 2568
130. J. Duplantier, K. Seyama, N. Day, R. Hitchcock, R.J. Nelson, and H. Ochs Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome Clin Immunol 98 2001 313 318
131. D. Brinkman, C. Jol-Van Der Zijde, M. Dam, J. Vossen, A. Osterhaus, and F. Kroon Vaccination with rabies to study the humoral cellular immune response to a T-cell dependent neoantigen in man J Clin Immunol 23 2003 528 538
132. K. Korver, E. Boeschoten, R. Krediet, G. Van Steenis, and P. Schellekens Dose-response effects in immunizations with keyhole limpet haemocyanin and rabies vaccine: shift in some immunodeficiency states Clin Exp Immunol 70 1987 328 335
133. S. Manning, C. Rupprecht, D. Fishbein, C. Hanlon, B. Lumlertdacha, and M. Guerra Human rabies prevention - United States 2008 Recommendations of the advisory committee on immunization practices MMWR Morb Mortal Wkly Rep 57 2008 1 28
134. CDCP Human rabies prevention-United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 48 1999 1 21
135. P. Amlot, A. Hayes, D. Gray, E. Gordon-Smith, and J. Humphrey Human immune responses in vivo to protein (KLH) and polysaccharide (DNP-Ficoll) neoantigens: normal subjects compared with bone marrow transplant patients on cyclosporine Clin Exp Immunol 64 1986 125 135
136. G. Ghaffari, D. Passalacqua, B. Bender, D. Briggs, M. Goodenow, and J. Sleasman Human lymphocyte proliferation responses following primary immunization with rabies vaccine as antigen Clin Diagn Lab Immunol 8 2001 883-3
137. E. Astoul, M. Lafage, and M. Lafon Rabies superantigen as a Vβ T-dependent adjuvant J Exp Med 183 1996 1623 1631
138. M. Lafon, M. Lafage, A. Martinez-Arends, R. Ramirez, F. Vuillier, and D. Charron Evidence for a viral superantigen in humans Nature 358 1992 507 510
139. U. Thisyakorn, C. Pancharoen, K. Ruxrungtham, S. Ubolyam, P. Khawplod, and T. Tantawichien Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1 Clin Infect Dis 30 2000 218
140. M. Van Zelm, I. Reisli, M. Van der Burg, D. Castano, C. Van Noesel, and M. Van Tol An antibody-deficiency syndrome due to mutations in the CD19 gene N Engl J Med 354 2006 1901 1912
141. K. Muhamuda, S. Madhusudana, and V. Ravi Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans Int J Infect Dis 11 2007 441 445
142. B.L. Ferry, S.A. Misbah, P. Stephens, Z. Sherrell, H. Lythgoe, and E. Bateman Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors Clin Exp Immunol 136 2004 297 303
143. USDH Code of Federal Regulations: Title 21, Volume 7, 600.3 2009 United States Department of Health and Human Services Code of Federal Regulations
144. D.S. McVey, J.E. Galvin, and S.C. Olson A review of the effectiveness of vaccine potency control testing Int J Parasitol 33 2003 507 516
145. R. Austrian Vaccines of pneumococcal capsular polysaccharides and the prevention of pneumococcal pneumonia R.J. Beers, E. Bassett, The role of immunological factors in infectious, allergic, and autoimmune processes 1976 Raven Press New York 79 89
146. J.M. Borgono, A.A. McLean, P.P. Vella, A.F. Woodhour, I. Canepa, and W.L. Davidson Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants Proc Soc Exp Biol Med 157 1978 148 154
147. M. Heidelberger Persistence of antibodies in man after immunization A.J. Pappenheimer, The nature and significance of the antibody response 1953 Columbia University Press New York 99 101
148. H. Ahman, H. Kayhty, H. Lehtonen, O. Leroy, J. Froeschle, and J. Eskola Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory Pediatr Infect Dis J 17 1998 211 216
149. H. Ahman, H. Kayhty, A. Vuorela, O. Leroy, and J. Eskola Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid Vaccine 17 1999 2726 2732
150. R.S. Daum, D. Hogerman, M.B. Rennels, K. Bewley, F. Malinoski, and E. Rothstein Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines J Infect Dis 176 1997 445 455
151. WHO Requirements for diphtheria, tetanus, pertussis and combined vaccines. Technical Report Series No. 800 1990 World Health Organization Geneva
152. J.M. Lieberman, W.R. Williams, J.M. Miller, S. Black, H. Shinefield, and F. Henderson The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody Pediatr Infect Dis J 25 2006 615 622
153. P. Smit, D. Oberholzer, S. Hayden-Smith, H.J. Koornhof, and M.R. Hilleman Protective efficacy of pneumococcal polysaccharide vaccines JAMA 238 1977 2613 2616
154. D.M. Granoff, M.H. Rathore, S.J. Holmes, P.D. Granoff, and A.H. Lucas Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines Vaccine 11 suppl 1 1993 S46 S51
155. D.P. Greenberg, J.I. Ward, K. Burkart, P.D. Christenson, L. Guravitz, and S.M. Marcy Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age Pediatr Infect Dis J 6 1987 660 665
156. K.M. Zangwill, D.P. Greenberg, C.Y. Chiu, P. Mendelman, V.K. Wong, and S.J. Chang Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants Vaccine 21 2003 1894 1900
157. S.A. Omilabu, A.O. Oyefolu, O.O. Ojo, and R.A. Audu Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria Afr J Med Sci 28 1999 209 212
158. L.A. Jackson, S. Falls, O. Yu, J. George, P.J. Pietrobon, and D. Rubanowice Diphtheria antitoxin levels among children primed with a diphtheria
159. V. Dietz, J.B. Milstien, F. van Loon, S. Cochi, and J. Bennett Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus Bull World Health Organ 74 1996 619 628
160. K. Alagappan, W. Rennie, V. Narang, and C. Auerbach Immunologic response to tetanus toxoid in geriatric patients Ann Emerg Med 30 1997 459 462
161. E. Talesnik, P. Vial, J. Labarca, C. Méndez, and X. Soza Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV J Acquir Immune Defic Syndr Hum Retrovirol 19 1998 471 477
162. P. Heath Haemophilus influenzae type b conjugate vaccines: a review of efficacy data Pediatr Infect Dis J 17 suppl 1998 S117 S122
163. T.V. Murphy Haemophilus influenzae vaccines: 1997 Adv Pediatr Infect Dis 13 1997 279 304
164. H. Käyhty, H. Ahman, K. Eriksson, M. Sörberg, and L. Nilsson Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age Pediatr Infect Dis J 24 2005 108 114
165. R. Prymula, P. Peeters, V. Chrobok, P. Kriz, E. Novakova, and E. Kaliskova Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study Lancet 367 2006 740 748
166. T. Kilpi, H. Ahman, J. Jokinen, K. Lankinen, A. Palmu, and H. Savolainen Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children Clin Infect Dis 37 2003 1155 1164
167. F. Oosterhuis-Kafeja, P. Beutels, and P. Van Damme Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006) Vaccine 25 2007 2194 2212